Last deal

Amount

Angel

Stage

08.09.2020

Date

1

all rounds

date founded

Financing round

General

About Company
Seragen Biotherapeutics offers biotherapeutics for infertility treatment.

Industry

Sector :

Subsector :

founded date

01.01.2018

Number of employees

Last funding type

Angel

IPO status

Private

Description

The company provides effective, affordable, and non-invasive treatments for male and female infertility conditions using regenerative medicines that are ready to use. Seragen's platform and therapeutic products help IVF specialists, Ob-Gyns, and Andrologists to maximize the effectiveness of their treatments. The company has successfully treated thousands of patients across 60+ IVF and Gynecology Centers in 6 cities, making it a leading reproductive health company.
Similar Companies
994
XY Therapeutics

XY Therapeutics

XY Therapeutics is a biotechnology research company developing a novel treatment for male infertility.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Copenhagen, Denmark
Notify Therapeutics

Notify Therapeutics

Notify Therapeutics develops first-in-class treatments for infertility by targeting early and hormone-independent phases of egg maturation.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology

Location

Copenhagen, Denmark

total rounds

2

total raised

$6.09M
Incintas Therapeutics

Incintas Therapeutics

Incintas Therapeutics is a biotechnology company that develops infertility and in-vitro fertilization therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Atglen, PA, USA
Igyxos

Igyxos

Igyxos is a company that develops innovative pharmaceuticals and medical technologies for addressing infertility in both men and women.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

37380 Nouzilly, France

total rounds

1

total raised

$6.59M

Financials

Funding Rounds
1
1

Number of Funding Rounds

Their latest funding was raised on 08.09.2020. Their latest round Angel

Date 
Funding Round 
Investors 
Money Raised 
Lead 
08.09.2020
Co-Investors

People

Employee Profiles
3
Srinivas Chari

Srinivas Chari

Chief Executive Officer

Srinivas Rangachari

Chief Executive Officer & Director

Vasanthi Palanivel

Co-Founder & Chief Scientific Officer

Activity

Recent News
0